Research / GHRH and GHS-receptor ligands
Category
Research ligands evaluated for receptor binding and GH-axis signaling in vitro. Lot-matched COA on request.
Biscayne Science holds a hard purity floor of at least 99% by HPLC on every compound, with mass-spectrometry identity confirmation. Endotoxin is screened to under 0.25 EU/mg by accredited LAL assay, and each batch is tested for sterility. Testing is done by an accredited third-party lab. A lot-matched Certificate of Analysis is available on request and is tied to the lot printed on the vial, not a representative sample from another batch.
A certificate reports those research results for that lot. It is not a representation that a material is safe or suitable for any use in humans or animals. The request path is the Certificate of Analysis page.
Comparison on this page is limited to the catalog description: which receptor language the listing uses, and which vial sizes exist. There is no ranking of experimental effect.
Modified GHRH(1-29) analog with Ipamorelin, evaluated for GHRH- and GHS-receptor binding in vitro. Compound note and 10 mg listing.
The shop name is Tesa. The catalog record full name is Tesamorelin. Stabilized GHRH(1-44) analog, evaluated for GHRH-receptor binding and GH-axis signaling in vitro. Compound note. Listings: 10 mg and 20 mg.
No. It repeats the in-vitro assay sentence from the catalog. Products are not for human use.
No. Tesa is the shop name. Tesamorelin is the full name on the same product record.
For laboratory research and in-vitro experimental use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Biscayne Science is a chemical research supplier, not a compounding pharmacy.
